VAXCYTE
Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Company’s cell-free protein synthesis platform, comprising the XpressCFTM platform, exclusively licensed from Sutro Biopharma, Inc., together with Vaxcyte’s proprietary know-how, enables the design and production of protein carriers and antigens, the critical building blocks o... f vaccines, in ways that the Company believes conventional vaccine technologies currently cannot. In addition to its pneumococcal conjugate vaccines in development, VAX-24 and VAX-XP, Vaxcyte is leveraging its proprietary platform to advance other novel vaccines, including a prophylactic vaccine to prevent Group A Strep infections (VAX-A1) and a therapeutic vaccine to treat periodontal disease (VAX-PG).
VAXCYTE
Industry:
Biopharma Biotechnology Health Care
Founded:
2013-12-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.vaxcyte.com
Total Employee:
251+
Status:
Active
Contact:
650-837-0111
Total Funding:
2.35 B USD
Technology used in webpage:
Domain Not Resolving SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare DNS WP Engine Smartsheet Dropbox Business
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Harmony Biosciences
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Kinarus Therapeutics (SIX:KNRS)
Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Nodexus
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Board_observer
2020-03-01
Board_member
2021-09-01
Board_member
2020-04-01
Board_member
2021-09-01
Board_member
2021-10-01
Board_member
2020-04-01
Board_member
2015-07-01
Board_observer
2020-03-01
Current Employees Featured
Grant E. Pickering Co-Founder, CEO & Director @ Vaxcyte
Co-Founder, CEO & Director
Moncef Slaoui Chairman @ Vaxcyte
Chairman
Paul W. Sauer Senior Vice President, Process Development & Manufacturing @ Vaxcyte
Senior Vice President, Process Development & Manufacturing
2016-04-01
Jim Wassil COO @ Vaxcyte
COO
Andrew Guggenhime President & Chief Financial Officer @ Vaxcyte
President & Chief Financial Officer
2021-01-01
Whitney Jones Chief People Officer @ Vaxcyte
Chief People Officer
2024-01-16
Jeff Fairman Founder & Vice President, Research @ Vaxcyte
Founder & Vice President, Research
2013-12-01
Founder
Stock Details
Investors List
CARB-X
CARB-X investment in Grant - Vaxcyte
CARB-X
CARB-X investment in Grant - Vaxcyte
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series D - Vaxcyte
Longitude Capital
Longitude Capital investment in Series D - Vaxcyte
CTI Life Sciences Fund
CTI Life Sciences Fund investment in Series D - Vaxcyte
RA Capital Management
RA Capital Management investment in Series D - Vaxcyte
Roche Venture Fund
Roche Venture Fund investment in Series D - Vaxcyte
TPG Growth
TPG Growth investment in Series D - Vaxcyte
Foresite Capital
Foresite Capital investment in Series D - Vaxcyte
Janus Henderson Investors
Janus Henderson Investors investment in Series D - Vaxcyte
Key Employee Changes
| Date | New article |
|---|---|
| 2024-01-16 | Vaxcyte Appoints Whitney Jones as Chief People Officer |
| 2022-10-11 | Vaxcyte Expands Executive Leadership Team with Key Appointments |
| 2020-01-30 | SutroVax Announces Executive Appointment |
Official Site Inspections
http://www.vaxcyte.com Semrush global rank: 2.19 M Semrush visits lastest month: 9.16 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Vaxcyte.com lookup results from whois.networksolutions.com server:
- Domain created: 17th-Jul-2019
- Domain updated: 18th-May-2024
- Domain expires: 17th-Jul-2025 0 Years, 82 Days left
- Website age: 5 Years, 282 Days
- Registrar Domain ID: 2414054927_DOMAIN_COM-VRSN
- Registrar Url: http://networksolutions.com
- Registrar WHOIS Server: whois.networksolutions.com
- Registrar Abuse Contact Email: domain.operations@web.com
- Registrar Abuse Contact Phone: +1.8777228662
- Name server:
- MEERA.NS.CLOUDFLARE.COM
- NORMAN.NS.CLOUDFLARE.COM
More informations about "Vaxcyte"
About Us - Vaxcyte
Vaxcyte is a clinical-stage vaccine innovation company based in San Carlos, California with the unique ability to rapidly engineer, optimize and manufacture superior, high-fidelity vaccines at …See details»
Mission - Vaxcyte
At Vaxcyte, we are driven by our: Bold Goal. To prevent or treat infections caused by bacterial diseases, such as invasive pneumococcal disease, Group A Strep, periodontitis and Shigella. Sense of Urgency.See details»
Vaxcyte - Crunchbase Company Profile & Funding
Organization. Vaxcyte . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Vaxcyte is a next …See details»
Corporate Governance - Vaxcyte, Inc.
The Board of Directors of Vaxcyte (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound …See details»
Investors & Media - Vaxcyte, Inc.
Feb 25, 2025 Vaxcyte’s early-stage pipeline includes VAX-A1, a prophylactic vaccine candidate designed to prevent disease caused by Group A Strep; VAX-PG, a therapeutic vaccine …See details»
Vaxcyte Expands Executive Leadership Team with Key Appointments
Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep …See details»
SutroVax Announces Name Change to Vaxcyte | Sutro Biopharma, …
Foster City, Calif., May 21, 2020 – SutroVax, Inc., a next-generation vaccine company, today announced that it has changed its name to Vaxcyte, Inc. The new name more accurately …See details»
Vaxcyte and Lonza Expand Collaboration for Global Commercial ...
Oct 16, 2023 Grant Pickering, Chief Executive Officer and Co-founder, Vaxcyte, commented: “Following the successful completion of our VAX-24 Phase 2 adult studies, and as we prepare …See details»
Working at Vaxcyte - Great Place To Work®
95% of employees at Vaxcyte say it is a great place to work . ... Today, our Trust Model™ offers an unmatched opportunity to identify what’s happening within your organization. Great …See details»
Vaxcyte Announces Positive Topline Results from VAX-24 Infant …
3 days ago Vaxcyte, Inc. Mon, Mar 31, 2025, 7:00 AM 13 min read. In This Article: PCVX . Vaxcyte, Inc.-- At All Doses Evaluated, VAX-24 Was Well-Tolerated and Demonstrated a …See details»
Vaxcyte - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Vaxcyte . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 7. ... Vaxcyte has 10 board …See details»
Working at Vaxcyte - Glassdoor
Mission: Vaxcyte is a people-first organization inspired by an audacious mission to develop best-in-class vaccines to prevent a host of deadly infectious diseases. Vaxcyte reviews. 4.1. 95% …See details»
Pipeline - Vaxcyte
At Vaxcyte, we are focusing our efforts on developing broadly protective vaccines to address the following: ... With the aim of reducing morbidity and mortality due to the disease, the World …See details»
Vaxcyte Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Vaxcyte (formerly known as SutroVax) is a company that develops vaccines designed to prevent or treat some of the most common and deadly infectious diseases. It …See details»
Vaxcyte - BioArk
Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company is developing broad-spectrum …See details»
Vaxcyte Information - RocketReach
Vaxcyte’s lead candidate, VAX-24, is a 24-valent, broad-spectrum pneumococcal conjugate vaccine being developed for the prevention of invasive pneumococcal disease. Vaxcyte is re …See details»
Vaxcyte Reviews: What Is It Like to Work At Vaxcyte?
Vaxcyte has an overall rating of 4.5 out of 5, based on over 21 reviews left anonymously by employees. 94% of employees would recommend working at Vaxcyte to a friend and 97% …See details»
Vaxcyte Announces Positive Topline Results from VAX-24 Infant …
2 days ago Streptococcus pneumoniae is among the World Health Organization’s top antibiotic-resistant pathogens to be urgently addressed, ... About Vaxcyte Vaxcyte is a vaccine …See details»
Vaxcyte Announces Positive Topline Results from VAX-24 Infant …
3 days ago Vaxcyte will hold a webcast and conference call today, March 31 at 8:00 a.m. ET to discuss the results from the VAX-24 infant Phase 2 study. ... Streptococcus pneumoniae is …See details»
Vaxcyte Announces Positive Topline Results from VAX-24
1 day ago Vaxcyte will hold a webcast and conference call today, March 31 at 8:00 a.m. ET to discuss the results from the VAX-24 infant Phase 2 study. ... Streptococcus pneumoniae is …See details»